Eliot Forster - 14 Sep 2023 Form 3 Insider Report for Protalix BioTherapeutics, Inc. (PLX)

Role
Director
Signature
/s/ Eyal Rubin, POA
Issuer symbol
PLX
Transactions as of
14 Sep 2023
Net transactions value
$0
Form type
3
Filing time
15 Sep 2023, 16:45:14 UTC
Previous filing
09 Mar 2023
Next filing
04 Sep 2025

No securities are beneficially owned.